Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdelfateh Chourir has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Naima El Hafidi

    Pediatric Translational Clinical Research Unit, Medical Biotechnology lab (MedBiotech) Bioinova Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco

    2 shared publications
  • Aya Abidou

    Pediatric Translational Clinical Research Unit, Medical Biotechnology lab (MedBiotech) Bioinova Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco

    1 shared publication
  • Aya Abidou

    Pediatric Translational Clinical Research Unit, Medical Biotechnology lab (MedBiotech) Bioinova Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco

    1 shared publication
  • Azeddine Ibrahimi

    Medical Biotechnology Laboratory, Faculty of Medicine and Pharmacy, Mohamed 5 Rabat University, Rabat 10000, Morocco

    1 shared publication
  • Boutaina Elgharbaoui

    Pediatric Translational Clinical Research Unit, Medical Biotechnology lab (MedBiotech) Bioinova Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco

    1 shared publication
  • Farah Makhloufi

    Pediatric Translational Clinical Research Unit, Medical Biotechnology lab (MedBiotech) Bioinova Research Center, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco

    1 shared publication

Latest Publications

  • Computational discovery of novel human rhinovirus 3 C protease inhibitors: molecular docking, dynamic simulations, free energy landscape, MMPBSA and ADMET analysis

    by Hafs Essaadi, Abdelfateh Chourir, Jouhaina Kourou, Farah Makhloufi, Ouissal Hachlaf, Aya Abidou, Saber Boutayeb, Rachid Eljaoudi, Lahcen Belyamani, Azeddine Ibrahimi, et al.

  • Open Access

    Design of a multiepitope immunotherapy for fish allergy

    by Abdelfateh Chourir, Hafs Essaadi, Farah Makhloufi, Aya Abidou, Ouissal Hachlaf, Zineb Lafi, Boutaina Elgharbaoui, Mohammed Hakmi, Rachid Eljaoudi, Naima El Hafidi

    Fish allergy is a significant global health concern and often leads to persistent and potentially severe hypersensitivity reactions. The molecular heterogeneity of fish allergens poses challenges for developing broadly applicable immunotherapies. In this study, an integrated immunoinformatics pipeline was used to design a multi-epitope vaccine construct targeting three major fish allergens: parvalbumin, enolase, and aldolase. Predicted B-cell and T-cell epitopes were screened for immunogenicity, non-allergenicity, and lack of toxicity, and the selected peptides were assembled into a 432-amino acid chimeric construct using rationally chosen linkers to facilitate antigen processing. Computational analyses predicted the construct to exhibit favorable physicochemical properties, including stability, solubility, and a broad theoretical population coverage. Docking and molecular dynamics simulations suggested a potential interaction with Toll-like receptor 4, offering preliminary insight into possible innate immune engagement. As these findings are entirely in silico, they represent a theoretical framework; experimental validation is necessary to determine the construct’s biological behavior, safety, and immunological relevance.